FDA Inspection 1046316 — Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc.
The FDA completed an inspection of Blood Bank Of Delmarva, A Division Of New York Blood Center, Inc. on Feb 20, 2018 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 20, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newark, DE (United States)